The Right Play On BioMarin Pharmaceuticals [Seeking Alpha]
Amicus Therapeutics (NASDAQ:FOLD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
FOLD Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Amicus Therapeutics, Inc. is Fair to Shareholders
Amicus Therapeutics (NASDAQ:FOLD) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.
Assessing Amicus Therapeutics (FOLD) Valuation After Recent Share Price Momentum [Yahoo! Finance]